Raymond R. Blush III is Clinical Assistant Professor, University of Michigan School of Nursing, Room 2304, 400 SNB N Ingalls, Ann Arbor, MI 48109 (
AACN Adv Crit Care. 2024 Sep 15;35(3):222-227. doi: 10.4037/aacnacc2024787.
β-Adrenergic agonist medications such as albuterol are the mainstay for treatment of patients with acute asthma exacerbations. Patients who present to the emergency department with severe symptoms are often treated with multiple albuterol doses in sequence to maximize the impact of the medications, relax bronchoconstriction, and relieve their breathlessness. Patients who present with acute dyspnea have numerous potential causes of hyperlactatemia and acidosis including an uncommonly recognized outcome of albuterol administration. This clinical case report outlines a scenario where a patient who was treated for an acute asthma exacerbation had rising lactate levels despite improving clinically. Causes of elevated lactate levels are discussed, particularly related to β-adrenergic agonist use, and considerations for monitoring and withdrawal of albuterol administration are outlined.
β-肾上腺素能激动剂药物,如沙丁胺醇,是治疗急性哮喘发作患者的主要药物。在急诊科就诊的严重症状患者通常会接受多次沙丁胺醇序贯治疗,以最大限度地发挥药物作用、缓解支气管痉挛和减轻呼吸困难。出现急性呼吸困难的患者有许多潜在的高乳酸血症和酸中毒原因,包括沙丁胺醇给药的一种罕见的认识结果。本临床病例报告概述了这样一种情况:一名接受急性哮喘发作治疗的患者尽管临床症状改善,但乳酸水平仍升高。讨论了升高的乳酸水平的原因,特别是与β-肾上腺素能激动剂使用有关,并概述了监测和停止沙丁胺醇给药的注意事项。